verified SJR 0,778 · Q2 • database Scopus / SJR & Web of Science indexed

United Kingdom · Informa Healthcare

workspace_premium Q2 — Hematology lock Subscription

Leukemia and Lymphoma

Leukemia and Lymphoma is a journal indexed in SJR in Hematology and Oncology with an H index of 105. It has a price of 2840 €. It has an SJR impact factor of 0,778 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,778.

Leukemia and Lymphoma focuses its scope in these topics and keywords: patients, lymphoma, leukemia, cell, cells, lymphoblastic, expression, treatment, receptor, myeloid, ...

ISSN: 1042-8194

Publisher: Informa Healthcare

Category: Hematology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,778 Q2

H-index 105

Acceptance rate pie_chart

25% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

2.840 € Subscription

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,778

H-index

105

Docs (year)

342

Docs 3y

1273

Total refs

11725

Cites 3y

1941

Citable 3y

807

Cites/Doc 2y

1.47

Ref/Doc

34.28

Immediate OA

2840 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Association study of a functional Toll-like receptor 4 polymorphism with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma

Viruses and Hodgkin lymphoma: No evidence of polyomavirus genomes in tumor biopsies

Current concepts in tumor imaging with whole-body MRI with diffusion imaging (WB-MRI-DWI) in multiple myeloma and lymphoma

Comparison of Bone Marrow Aspirates and Biopsies in Pediatric Patients with ALL at Days 7 and 14 of Induction Therapy

Changing Prognostic Role of Preserved Dendritic Cell Reticulum in Hodgkin's Lymphoma

CD20 expression in angioimmunoblastic T cell lymphoma

Cardiac morbidity following modern treatment for Hodgkin lymphoma: Supra-additive cardiotoxicity of doxorubicin and radiation therapy

Burkitt's Lymphoma of the Stomach: a Case Report with Molecular Cytogenetic Analysis

Breast Cancer Resistance Protein (BCRP) in Acute Leukaemia

Brain Abscess during Induction in Acute Lymphoblastic Leukemia. A Case Report

Bone Marrow Transplantation in Jehovah's Witnesses

Bone Marrow Mastocytosis Associated with IgM Kappa Plasma Cell Myeloma

SHOW MORE ARTICLES

Autoimmune Myelofibrosis: Report of Three Cases and Review of the Literature

A Novel ALL-L3 Cell Line, BALM-25, Expressing Both Immunoglobulin Light Chains

Association ofGSTT1polymorphism with acute myeloid leukemia risk is dependent on smoking status

Association Between SV40 and Non-Hodgkin's Lymphoma

An abscopal effect may augment PD-1 inhibition in refractory classical Hodgkin lymphoma

Allogeneic transplantation for relapsed and refractory Hodgkin lymphoma: long-term outcomes and graft-versus-host disease-free/relapse-free survival

Allogeneic Bone Marrow Transplantation from an Unrelated Donor for the Treatment of Chronic Myelogenous Leukemia in Blast Crisis in a Patient with Kleinfelter's Syndrome

Agnogenic Myeloid Metaplasia with Pleural Extramedullary Leukemic Transformation

Adult T-Cell Leukemia/Lymphoma in London: Clinical Experience of 21 Cases

Acute Renal Failure Due to Leukemic Cell Infiltration Followed by Relapse at Multiple Extramedullary Sites in a Child with Acute Lymphoblastic Leukemia

Acute Myelogenous Leukemia with Splenic Infarcts Presenting as Fulminant Multi-organ Failure

Acute Basophilic Leukemia with t(8;21)

FAQs

Leukemia and Lymphoma has an SJR of 0,778 (best quartile Q2) in the CountryOfPapers database.

Immediate OA APC is 2840 EUR. Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for Leukemia and Lymphoma is 25%.

Leukemia and Lymphoma

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Leukemia and Lymphoma?

What is the APC / publication cost?

What is the acceptance rate?